Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Rasagiline on Sleep Disturbances in PD: A Single Center, Randomized, Double-blind, Placebo run-in, Polysomnographic Clinical Phase IV Trial

NCT01442610 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT01442610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01442610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Rasagiline on Sleep Disturbances in PD: A Single Center, Randomized, Double-blind, Placebo run-in, Polysomnographic Clinical Phase IV Trial
Lead sponsor
Technische Universität Dresden
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
September 30, 2015
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinsons's disease, sleep disturbances